Skip to main content

U.S. pauses use of J&J’s COVID-19 vaccine after reports of rare blood clots

U.S. regulators have temporarily halted use of Johnson & Johnson's COVID-19 vaccine while they examine six cases of rare blood clots that have been reported in people who have received the shot.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.